Since 1992, when the FDA first gave its approval for the release of Paxil in the U.S. market, it has been one long rollercoaster ride for the drug manufacturer, GlaxoSmithKline, GSK. Generating annual sales of up to 2 billion dollars, Paxil has been prescribed for the treatment of depression, and a large variety of other "disorders", many of which the American public had never heard of before...